205 related articles for article (PubMed ID: 31035425)
41. Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes.
Wang S; Zhao C; Liu Z; Wang X; Liu N; Du W; Dai Q
Mar Drugs; 2015 May; 13(6):3259-75. PubMed ID: 26023835
[TBL] [Abstract][Full Text] [Related]
42. Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor.
Jiang S; Tae HS; Xu S; Shao X; Adams DJ; Wang C
Mar Drugs; 2017 Jun; 15(6):. PubMed ID: 28598389
[TBL] [Abstract][Full Text] [Related]
43. Isolation and characterization of α-conotoxin LsIA with potent activity at nicotinic acetylcholine receptors.
Inserra MC; Kompella SN; Vetter I; Brust A; Daly NL; Cuny H; Craik DJ; Alewood PF; Adams DJ; Lewis RJ
Biochem Pharmacol; 2013 Sep; 86(6):791-9. PubMed ID: 23924607
[TBL] [Abstract][Full Text] [Related]
44. Molecular Determinants of Species Specificity of α-Conotoxin TxIB towards Rat and Human α6/α3β4 Nicotinic Acetylcholine Receptors.
Xie T; Qin Y; Zhao J; Dong J; Qi P; Zhang P; Zhangsun D; Zhu X; Yu J; Luo S
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239959
[TBL] [Abstract][Full Text] [Related]
45. A Novel Lid-Covering Peptide Inhibitor of Nicotinic Acetylcholine Receptors Derived from αD-Conotoxin GeXXA.
Yang L; Tae HS; Fan Z; Shao X; Xu S; Zhao S; Adams DJ; Wang C
Mar Drugs; 2017 Jun; 15(6):. PubMed ID: 28587231
[TBL] [Abstract][Full Text] [Related]
46. Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors.
López-Vera E; Aguilar MB; Schiavon E; Marinzi C; Ortiz E; Restano Cassulini R; Batista CV; Possani LD; Heimer de la Cotera EP; Peri F; Becerril B; Wanke E
FEBS J; 2007 Aug; 274(15):3972-85. PubMed ID: 17635581
[TBL] [Abstract][Full Text] [Related]
47. Stoichiometry dependent inhibition of rat α3β4 nicotinic acetylcholine receptor by the ribbon isomer of α-conotoxin AuIB.
Wu X; Tae HS; Huang YH; Adams DJ; Craik DJ; Kaas Q
Biochem Pharmacol; 2018 Sep; 155():288-297. PubMed ID: 30009767
[TBL] [Abstract][Full Text] [Related]
48. Relating neuronal nicotinic acetylcholine receptor subtypes defined by subunit composition and channel function.
Nai Q; McIntosh JM; Margiotta JF
Mol Pharmacol; 2003 Feb; 63(2):311-24. PubMed ID: 12527802
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and evaluation of disulfide-rich cyclic α-conotoxin [S9A]TxID analogues as novel α3β4 nAChR antagonists.
Wang S; Ren J; Li R; Li X; Zhangsun D; Wu Y; Luo S
Bioorg Chem; 2021 Jul; 112():104875. PubMed ID: 33823404
[TBL] [Abstract][Full Text] [Related]
50. α-Conotoxins and α-Cobratoxin Promote, while Lipoxygenase and Cyclooxygenase Inhibitors Suppress the Proliferation of Glioma C6 Cells.
Terpinskaya TI; Osipov AV; Kryukova EV; Kudryavtsev DS; Kopylova NV; Yanchanka TL; Palukoshka AF; Gondarenko EA; Zhmak MN; Tsetlin VI; Utkin YN
Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33669933
[TBL] [Abstract][Full Text] [Related]
51. Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M
Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168
[TBL] [Abstract][Full Text] [Related]
52. A novel conotoxin inhibitor of Kv1.6 channel and nAChR subtypes defines a new superfamily of conotoxins.
Imperial JS; Bansal PS; Alewood PF; Daly NL; Craik DJ; Sporning A; Terlau H; López-Vera E; Bandyopadhyay PK; Olivera BM
Biochemistry; 2006 Jul; 45(27):8331-40. PubMed ID: 16819832
[TBL] [Abstract][Full Text] [Related]
53. Human nicotinic receptors in chromaffin cells: characterization and pharmacology.
Albillos A; McIntosh JM
Pflugers Arch; 2018 Jan; 470(1):21-27. PubMed ID: 29058146
[TBL] [Abstract][Full Text] [Related]
54. Subtype-selective conopeptides targeted to nicotinic receptors: Concerted discovery and biomedical applications.
Olivera BM; Quik M; Vincler M; McIntosh JM
Channels (Austin); 2008; 2(2):143-52. PubMed ID: 18849660
[TBL] [Abstract][Full Text] [Related]
55. Design and synthesis of α-conotoxin GID analogues as selective α4β2 nicotinic acetylcholine receptor antagonists.
Banerjee J; Yongye AB; Chang YP; Gyanda R; Medina-Franco JL; Armishaw CJ
Biopolymers; 2014 Jan; 102(1):78-87. PubMed ID: 24122487
[TBL] [Abstract][Full Text] [Related]
56. α9α10 nicotinic acetylcholine receptors regulate murine bone marrow granulocyte functions.
Safronova VG; Vulfius CA; Astashev ME; Tikhonova IV; Serov DA; Jirova EA; Pershina EV; Senko DA; Zhmak MN; Kasheverov IE; Tsetlin VI
Immunobiology; 2021 Jan; 226(1):152047. PubMed ID: 33340828
[TBL] [Abstract][Full Text] [Related]
57. Lyophilization Serves as an Effective Strategy for Drug Development of the α9α10 Nicotinic Acetylcholine Receptor Antagonist α-Conotoxin GeXIVA[1,2].
Li Z; Han X; Hong X; Li X; Gao J; Zhang H; Zheng A
Mar Drugs; 2021 Feb; 19(3):. PubMed ID: 33668830
[TBL] [Abstract][Full Text] [Related]
58. α-Conotoxins to explore the molecular, physiological and pathophysiological functions of neuronal nicotinic acetylcholine receptors.
Giribaldi J; Dutertre S
Neurosci Lett; 2018 Jul; 679():24-34. PubMed ID: 29199094
[TBL] [Abstract][Full Text] [Related]
59. Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors.
Vincler M; Wittenauer S; Parker R; Ellison M; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17880-4. PubMed ID: 17101979
[TBL] [Abstract][Full Text] [Related]
60. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
McIntosh JM; Azam L; Staheli S; Dowell C; Lindstrom JM; Kuryatov A; Garrett JE; Marks MJ; Whiteaker P
Mol Pharmacol; 2004 Apr; 65(4):944-52. PubMed ID: 15044624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
